Purple Biotech Ltd
PPBT
$2.99
$0.072.40%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -5,642.68% | 54.89% | 87.96% | 91.51% | |
| Total Depreciation and Amortization | 32.50% | -4.08% | -6.25% | -16.67% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 3,309.22% | 83.89% | -96.35% | 49.13% | |
| Change in Net Operating Assets | 287.85% | 60.66% | 23.66% | -195.08% | |
| Cash from Operations | 47.02% | 61.17% | 61.08% | 59.57% | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -350.00% | 25.29% | -17.63% | -48.65% | |
| Cash from Investing | -373.68% | 22.99% | -17.63% | -48.65% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -27.08% | 15.22% | -17.78% | -14.29% | |
| Issuance of Common Stock | -94.09% | -21.45% | -40.91% | 109,075.00% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 126.32% | 55.29% | -6.56% | -108.87% | |
| Cash from Financing | -92.46% | -15.47% | -61.57% | -7.23% | |
| Foreign Exchange rate Adjustments | -- | 800.00% | -450.00% | -100.00% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -144.57% | 70.07% | 63.83% | 419.19% | |